ANDREW C. SHAW M.D. NPI 1558686915

NPI Information

  • NPI: 1558686915
  • Provider Name: ANDREW C. SHAW, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1401 MEDICAL PKWY STE 412
    CEDAR PARK, TX
    ZIP 78613
  • Phone: (512) 260-6050

Map and Directions

Get Directions

NPI Details

Andrew C. Shaw, M.D. is a hematology and oncology internal medicine in Cedar Park, TX with 16 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Andrew C. Shaw, M.D. NPI is 1558686915. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF TEXAS MEDICAL SCHOOL AT HOUSTON
Graduation Year:2010

The provider's business location address is:

1401 MEDICAL PKWY STE 412
CEDAR PARK, TX
ZIP 78613-015
Phone: (512) 260-6050
Fax: (512) 260-6080

The NPI 1558686915 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, iron sucrose, 1 mg (HCPCS:J1756)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
  • Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
  • Measurement of immunoglobulin light chains (HCPCS:83521)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Protein measurement, serum (HCPCS:84165)
  • Immunologic analysis technique on serum (HCPCS:86320)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Folic acid level, serum (HCPCS:82746)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Red blood count, automated test (HCPCS:85045)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Magnesium level (HCPCS:83735)
  • Unclassified drugs (HCPCS:J3490)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Automated urinalysis test (HCPCS:81003)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Vitamin d-3 level (HCPCS:82306)
  • Testosterone (hormone) level, total (HCPCS:84403)

The enumeration date for this NPI number is 3/29/2010 and was last updated on 3/17/2018.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207R00000XInternal Medicine0101254622VIRGINIANo
2207R00000XInternal MedicineQ0699TEXASNo
3390200000XStudent in an Organized Health Care Education/Training ProgramNo
4207RH0003XInternal MedicineHematology & OncologyQ0699TEXASYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1P01880005OTHERTEXASRAILROAD
2338506401MEDICAIDTEXAS

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.